公开(公告)号：US10799520B2

公开(公告)日：2020-10-13

申请号：US15923679

申请日：2018-03-16

Applicant: Northwestern University

Inventor： Stephen F. Murphy ,  Praveen Thumbikat ,  Anthony Schaeffer

IPC: A61K31/7032 ,  A61K35/741 ,  A61P29/00 ,  A61P19/02 ,  A61K9/00 ,  A61P37/06 ,  A61K35/00

Abstract: Provided herein are compositions comprising lipotechoic acid (LTA) and methods of use thereof for immune modulation. In particular, compositions comprising S. epidermidis lipotechoic Acid (SELTA) are provided, as well as method of use thereof for the treatment of immune- (e.g., autoimmune) and inflammation-related conditions and diseases (e.g., chronic pelvic pain syndrome (CPPS), arthritis, etc.).

公开(公告)号：US20180280419A1

公开(公告)日：2018-10-04

申请号：US15923679

申请日：2018-03-16

Applicant: Northwestern University

Inventor： Stephen F. Murphy ,  Praveen Thumbikat ,  Anthony Schaeffer

IPC: A61K31/7032 ,  A61K35/741 ,  A61P29/00 ,  A61P37/06 ,  A61P19/02 ,  A61K9/00

CPC classification number: A61K31/7032 ,  A61K9/0031 ,  A61K9/0053 ,  A61K35/741 ,  A61K2035/115 ,  A61P19/02 ,  A61P29/00 ,  A61P37/06

Abstract: Provided herein are compositions comprising lipotechoic acid (LTA) and methods of use thereof for immune modulation. In particular, compositions comprising S. epidermidis lipotechoic Acid (SELTA) are provided, as well as method of use thereof for the treatment of immune- (e.g., autoimmune) and inflammation-related conditions and diseases (e.g., chronic pelvic pain syndrome (CPPS), arthritis, etc.).

公开(公告)号：US12233080B2

公开(公告)日：2025-02-25

申请号：US17037079

申请日：2020-09-29

Applicant: Northwestern University

Inventor： Stephen F. Murphy ,  Praveen Thumbikat ,  Anthony Schaeffer

IPC: A61K39/085 ,  A61K9/00 ,  A61K31/7032 ,  A61K35/00 ,  A61K35/741 ,  A61P19/02 ,  A61P29/00 ,  A61P37/06

Abstract: Provided herein are compositions comprising lipotechoic acid (LTA) and methods of use thereof for immune modulation. In particular, compositions comprising S. epidermidis lipotechoic Acid (SELTA) are provided, as well as method of use thereof for the treatment of immune—(e.g., autoimmune) and inflammation-related conditions and diseases (e.g., chronic pelvic pain syndrome (CPPS), arthritis, etc.).

公开(公告)号：US20210023109A1

公开(公告)日：2021-01-28

申请号：US17037079

申请日：2020-09-29

Applicant: Northwestern University

Inventor： Stephen F. Murphy ,  Praveen Thumbikat ,  Anthony Schaeffer

IPC: A61K31/7032 ,  A61K35/741 ,  A61P29/00 ,  A61P19/02 ,  A61K9/00 ,  A61P37/06

Abstract: Provided herein are compositions comprising lipotechoic acid (LTA) and methods of use thereof for immune modulation. In particular, compositions comprising S. epidermidis lipotechoic Acid (SELTA) are provided, as well as method of use thereof for the treatment of immune- (e.g., autoimmune) and inflammation-related conditions and diseases (e.g., chronic pelvic pain syndrome (CPPS), arthritis, etc.).